Abstract

Developing new therapeutic drugs to prevent ischemia/reperfusion (I/R)-induced renal injuries is highly pursued. Liposomal encapsulation of spironolactone (SP) as a mineralocorticoid antagonist increases dissolution rate, bioavailability and prevents the drug from degradation. In this context, this work develops a new formulation of oil-in-water type microemulsions to enhance the bioavailability of SP. The size of the SP-loaded microemulsion was about 6.0 nm by dynamic light scattering analysis. Briefly, we investigated the effects of nano-encapsulated SP (NESP) on renal oxidative stress, biochemical markers and histopathological changes in a rat model of renal I/R injury. Forty eight male Wistar rats were divided into six groups. Two groups served as control and injury model (I/R). Two groups received “conventional” SP administration (20 mg/kg) and NESP (20 mg/kg), respectively, for two days. The remaining two groups received SP (20 mg/kg) and NESP (20 mg/kg) two days before induction of I/R. At the end of the experiments, serum and kidneys of rats underwent biochemical, molecular and histological examinations. Our results showed that I/R induces renal oxidative stress, abnormal histological features and altered levels of renal biomarkers. Administration of SP in healthy animals did not cause any significant changes in the measured biochemical and histological parameters compared to the control group. However, SP administration in the I/R group caused some corrections in renal injury, although it could not completely restore I/R-induced renal oxidative stress and kidney damage. On the contrary, NESP administration restored kidney oxidative injury via decreasing renal lipid peroxidation and enhancing glutathione, superoxide dismutase and catalase in kidneys of the I/R group. The deviated serum levels of urea, creatinine, total proteins and uric acid were also normalized by NESP administration. Furthermore, NESP protected against renal abnormal histology features induced by I/R. Therefore, NESP has beneficial effects in preventing kidney damage and renal oxidative stress in a rat model of I/R, which deserves further evaluations in the future.

Highlights

  • Renal ischemia/reperfusion (I/R) accrues from a decrease in total or regional renal blood flow, followed by consequent restoration [1]

  • To the best of the authors’ knowledge, there is no previous study investigating the effects of nano-encapsulated SP (NESP) on animal models of renal injury; our study is the first report comparing the effects of orally administration of free SP and NESP in a rat model of renal I/R

  • Our results were quite promising in showing the beneficial effects of orally-administered NESP pre-treatment (20 mg/kg) for 2 days before ischemia induction compared to free SP, administered in the same period, on improvement of renal injury through normalizing oxidant/antioxidant imbalance, renal biomarkers and histological features in rats

Read more

Summary

Introduction

Renal ischemia/reperfusion (I/R) accrues from a decrease in total or regional renal blood flow, followed by consequent restoration [1]. Various clinical conditions such as cardiac surgery, sepsis, trauma and kidney transplantation may lead to renal ischemia [2]. There are various strategies to prevent I/R injury; this complication can lead to high mortality [5]. Newly developed therapeutic drugs and interventions addressed to the prevention of I/R-induced renal injuries are strongly pursued. The design of drugs that regulate factors affecting tissue blood flow can play an important role in preventing damage caused by renal ischemia

Methods
Findings
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.